ATARA BIO
Live / Applied — Statement of use — final refusal mailed (as of 21 Jan 2026)
What this means for you
Not registered yet, but its 22 Apr 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90664858
- Mark type
- Design + words
- Filed
- 22 Apr 2021
- Published for opposition
- 25 Jan 2022
- Attorney of record
- Lynne Boisineau
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis
Owner
- Atara Biotherapeutics, Inc., Thousand Oaks, CA, US
- Atara Biotherapeutics, Inc., San Francisco, CA, US
Prosecution history
- 21 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Jan 2026 — FINAL REFUSAL E-MAILED
- 21 Jan 2026 — SU - FINAL REFUSAL - WRITTEN
- 02 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Dec 2025 — ASSIGNED TO LIE
- 16 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Aug 2025 — NON-FINAL ACTION E-MAILED
- 20 Aug 2025 — SU - NON-FINAL ACTION - WRITTEN
- 17 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Mar 2025 — USE AMENDMENT FILED
- 17 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED